Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $0.14 (loss) per share for the year ending 2025.
- LEXICON PHARMACEUTICALS, INC. showed an increase of +77.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $0.26 (loss) per share | Q1 2019: $0.21 (loss) per share | Q2 2019: $0.22 (loss) per share | Q3 2019: $1.95 per share | Q4 2019: $0.48 (loss) per share | Q3 2020: $0.71 per share | Q3 2021: $0.16 (loss) per share | Q3 2022: $0.13 (loss) per share | Q1 2023: $0.17 (loss) per share | Q2 2023: $0.22 (loss) per share | Q3 2023: $0.21 (loss) per share | Q1 2024: $0.20 (loss) per share | Q2 2024: $0.17 (loss) per share | Q3 2024: $0.18 (loss) per share | Q1 2025: $0.07 (loss) per share | Q2 2025: $0.01 per share | Q3 2025: $0.04 (loss) per share.
- Over the full 9 years of available data (2017 to 2025), LEXICON PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 88.0%.
- Historical annual values: Fiscal year 2025: $0.14 (loss) per share | Fiscal year 2024: $0.63 (loss) per share | Fiscal year 2023: $0.80 (loss) per share | Fiscal year 2022: $0.62 (loss) per share | Fiscal year 2021: $0.60 (loss) per share | Fiscal year 2020: $0.53 (loss) per share | Fiscal year 2019: $1.16 per share | Fiscal year 2018: $1.14 (loss) per share | Fiscal year 2017: $1.17 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: